You are here


A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Type of Sarcoma: 
Refractory Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcomas, Rhabdomyosarcoma, Mesenchymal Chondrosarcoma
Accrual Status: 
Overall Study Principal Investigator: 
Robert Maki, MD, PhD
Professor of Medicine
Abramson Cancer Center
University of Pennsylvania School of Medicine
Co-Principal Investigators: 
Richard F. Riedel, MD
Associate Professor of Medicine
Duke University School of Medicine

Christopher W. Ryan, MD
Medical Oncologist
Oregon Health and Science University

Steven Attia, DO
Medical Oncologist
Mayo Clinic

Lara E. Davis
Assistant Professor of Medicine
Oregon Health and Science University

Leo Mascarenhas, MD, MS
Pediatric Hematologist-Oncologist
Children's Hospital Los Angeles

For more information about this trial and open sites: